Latest Breaking News On - Nabriva therapeutics - Page 3 : comparemela.com

Investment Analysts New Coverage for April 9th (ALPN, AMKR, APH, ARKR, ARL, AVDX, BTDR, CDE, CSCO, DGLY)

Investment Analysts’ new coverage for Tuesday, April 9th: Guggenheim initiated coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN). Guggenheim issued a buy rating and a $55.00 price target on the stock. Needham & Company LLC assumed coverage on shares of Amkor Technology (NASDAQ:AMKR). The firm issued a buy rating and a $40.00 price target on […]

United statesRaymond jamesPiper sandlerCraig hallumRoth mkmJuniper networksGoldman sachs group incAmkor technologyTech internationalMaxim groupAmerica coAlpine immune sciences incFrontier communications parentMorgan stanleyQualtrics internationalWells fargo company

Equities Research Analysts New Coverage for April 1st (AMS, ARKR, ARL, BE, CCJ, CIVB, CMPS, CROX, DECK, DGLY)

Equities Research Analysts’ new coverage for Monday, April 1st: StockNews.com assumed coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS). The firm issued a hold rating on the stock. StockNews.com assumed coverage on shares of Ark Restaurants (NASDAQ:ARKR). StockNews.com issued a buy rating on the stock. StockNews.com assumed coverage on shares of American Realty Investors […]

United statesAmerican realty investorsTech internationalPeoples bancorpJuniper networksEquities research analystInteractive softwareVia renewablesTextainer groupJefferies financial group incQualtrics internationalHovde groupGoldman sachs group incMorgan stanleyNexgen energyBarclays plc

Nabriva Therapeutics (NASDAQ:NBRV) Research Coverage Started at StockNews com

StockNews.com initiated coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance Nabriva Therapeutics has a 12-month low of $1.22 and a 12-month high of $8.45. The company has a debt-to-equity […]

Exchange commissionRenaissance technologiesNabriva therapeuticsFree reportGet free reportNabriva therapeutics daily

Nabriva Therapeutics (NASDAQ:NBRV) Coverage Initiated at StockNews com

Equities researchers at StockNews.com began coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance The company has a quick ratio of 0.52, a current ratio of 0.85 and a […]

Renaissance technologiesExchange commissionNabriva therapeuticsGet free reportFree reportNabriva therapeutics daily

Investment Analysts New Coverage for March 24th (ARKR, ARL, DGLY, FLNT, HES, IPW, JNPR, LEDS, NBRV, NSTG)

Investment Analysts New Coverage for March 24th (ARKR, ARL, DGLY, FLNT, HES, IPW, JNPR, LEDS, NBRV, NSTG)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesArk restaurants corpNews ratings for ark restaurants corp dailyTech internationalAmerican realty investorsQualtrics internationalOrion energy systemsUs energyTextainer groupVia renewablesJuniper networksInvestment analystPark restaurantsDigital allyNabriva therapeuticsNanostring technologies